Urinalysis Market Size, Trends and Growth Analysis by 2027

The urinalysis market is anticipated to grow significantly, reaching an estimated US$ 5,937.97 million by 2028, up from US$ 4,065.79 million in 2021. This growth represents a compound annual growth rate (CAGR) of 5.6% from 2021 to 2028.

Several factors contribute to this market expansion, including the increasing incidence of urinary tract infections (UTIs), diabetes, and kidney-related diseases, alongside a rise in age-associated health issues. However, the market faces challenges such as stringent regulatory standards and product recalls that hinder its growth. For example, in January 2020, Beckman Coulter Inc. was compelled to recall its automated urinalysis systems from the market.

Urinalysis plays a crucial role in diagnosing and managing various health conditions, including kidney diseases, UTIs, and diabetes. Essentially, urinalysis is a comprehensive examination of urine, utilizing chemical, physical, and microscopic methods to identify the presence of drugs and diseases. This analysis involves assessing the concentration, appearance, and composition of urine. Abnormal results from urinalysis can indicate potential health issues, such as kidney dysfunction or cardiovascular diseases. Additionally, urinalysis is instrumental in detecting pregnancy and ovulation.

According to a study conducted by researchers at the American College of Physicians and the Infectious Diseases Society of America in 2020, approximately 6 million individuals in the United States seek medical attention for UTIs annually. Women are particularly susceptible to these infections compared to men. A 2019 study published in the International Journal of Environmental Research and Public Health highlighted that patients with chronic conditions, such as diabetes mellitus, face a heightened risk of developing UTIs. The demand for urinalysis components is surging due to the widespread prevalence of diabetes, as urinalysis is a primary screening tool for this condition. The International Diabetes Federation (IDF) reported that around 463 million adults aged 20-79 were living with diabetes globally in 2019, a figure projected to rise to 700 million by 2045. In Southeast Asia alone, approximately 87.6 million adults in the same age group were diagnosed with diabetes in 2019, with a significant portion remaining undiagnosed, indicating substantial market potential for urinalysis.

Furthermore, a study by the National Kidney Foundation in 2020 revealed that about 35.0% of the diabetic population over 20 years old would likely develop chronic kidney diseases over time. The increasing rates of prostate and bladder cancer further emphasize the urgent need for effective diagnostic tools.

Consequently, the rising prevalence of UTIs, diabetes, and kidney diseases is a significant driver of growth in the urinalysis market.

The COVID-19 pandemic has posed unprecedented challenges to global health, leading to lockdowns that caused many individuals to postpone health checkups. This delay adversely affected the number of tests conducted and the sales of related instruments, consumables, and reagents. Initially, the urinalysis market experienced a downturn due to supply chain disruptions and decreased demand during the early stages of the pandemic. However, as restrictions are gradually lifted, there has been a noticeable rebound in testing numbers.

The urinalysis market is categorized by product type into consumables and instruments. The consumables segment is expected to dominate the market share in 2021 and is projected to exhibit the highest CAGR during the forecast period.

In terms of test types, the urinalysis market is divided into pregnancy and fertility tests, biochemical urinalysis, and sediment urinalysis. The biochemical urinalysis segment is anticipated to hold the largest market share in 2021 and is expected to grow at the fastest rate from 2021 to 2028, driven by the increasing adoption of biochemical testing methods.

When considering applications, the market is segmented into disease screening and pregnancy and fertility testing. The disease screening segment is projected to account for the largest market share in 2021 and is expected to experience the highest growth rate during the forecast period.

Regarding end users, the urinalysis market is divided into hospitals and clinics, diagnostic laboratories, home care settings, and research laboratories and institutes. The hospitals and clinics segment is expected to hold the largest market share in 2021, while the diagnostic laboratories segment is projected to register the highest CAGR during the forecast period.

Key organizations and sources that have been referenced in the preparation of this report include the International Diabetes Federation, Centers for Medicare & Medicaid Services, European Association of Urology, National Kidney Foundation, Food and Drug Administration, World Health Organization, and Centers for Disease Control and Prevention.